CannAssist International Corp.

Investor Relations


Cannassist International Corp, providing the best premium CBD Products available with Xceptol and 2CYTE Brands.

CannAssist International Corporation is pleased to announce our Reg. A+ Tier 2 Filing has been approved by the SEC. Investors now have an opportunity to purchase shares at a set price stated in the filing.

“CannAssist International is building digital platforms, implement a Brand PR and Sales/Marketing Campaign, expanding distribution, building inventory and enhancing the Xceptol brand.” - Mark Palumbo, CEO

Mark also states, “Gaining approval for the CNSC Reg A offering is an exciting milestone for us as it opens doors for new investors. The Capital will help CannAssist’s continued expansion of the brand and help us reach our corporate benchmarks in order to help as many as possible through our unique technology.”

Interested in learning more about our investment opportunity?

  • Email us at

  • Call our investor relations department at +1 888-507-6846

  • Utilize our "contact us" page

    Click here to download our Company Profile

In a crowded field of Cannabis, growers, producers, consumer products and everything else under the sun CBD-related, CannAssist International stands tall, while waving the flag of transparency.


CEO and Founder, Mark Palumbo, says “We didn’t jump into the CBD game as if it were the new fad; we’ve been honing  2CYTE technology for years.  When CBD burst onto the scene, I knew we had something that would be a game-changer.  Putting oil into a water system (our body) has limited bioavailability; 2CYTE allows for up to 300% increased absorption both topically and in the gut.”



CannAssist International is the parent company that owns 2CYTE technology.  As we continue to partner with the industry's top extractors, terpene companies, manufacturers, and consumer lines, we continue to grow our technology domestically and abroad. 

First to Know

Be the first to find out all the latest news, PR releases, and announcements.

Latest   PR Releases

4/06/21 -  CannAssist International Signs Strategic Partnership with NectarTek LLC

Read Full Statement

12/21/20 CannAssist International Corporation (CNSC) Xceptol Brand Available via Innovative Distribution Portal - RangeMe

Read Full Statement

12/10/20 - CannAssist International Corporation (CNSC) Engages InvestorBrandNetwork for Corporate Communications Expertise

Read Full Statement

12/04/20CannAssist International Corporation's (CNSC) Reg. A Offering Capital to Boost Continued Brand Expansion, Benchmarks

Read Full Statement

12/03/20CannAssist International Corporation (CNSC) commences Trading on the OTCQB.

Read Full Statement

12/02/20 -   CannAssist International Corp. (OTCQB:  CNSC ), owner of Xceptor Labs, is a biotechnological pharmaceutical and wellness company marketing the Xceptol consumer brand. 

Read Full Statement


Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended.  Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements".  Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as "expects", "will", "anticipates", "estimates", "believes", or by statements indicating certain actions "may", "could", "should" or "might" occur.

To install this Web App in your iPhone/iPad press and then Add to Home Screen.